AERI Aerie Pharmaceuticals Inc

Small-cap biotech Catalyst Pharmaceuticals recently joined the S&P 600 index, which means institutions must own shares to track the index The company has a steady history of price appreciation going back one year, even while the broad market declined Catalyst has been outpacing the S&P 600 index by a wide margin The company’s earnings and […]
https://www.valuewalk.com/small-cap-catalyst-pharmaceuticals-is-among-markets-best-price-performers/